Good news: Dingchi's new veterinary drug "Combined Newcastle Disease and Avian Influenza(Subtype H9) Vaccine, Inactivated" has been approved!

On December 23, 2024, Announcement No. 860 of the Ministry of Agriculture and Rural Affairs of the People’s Republic of China was issued, and Beijing Dingchi Biology Technology CO., LTD was approved as a national Class III new veterinary drug for the "Combined Newcastle Disease and Avian Influenza(Subtype H9) Vaccine, Inactivated".(https://www.moa.gov.cn/govpublic/xmsyj/202412/t20241223_6468375.htm)

The successful approval of Dingchi Bio's new bivalent inactivated vaccine will further promote the improvement of the disease prevention and control level in the industry and promote the aquaculture industry to develop in a healthier and more sustainable direction.Dingchi Bio will also continue to be committed to providing farmers with more comprehensive and higher-quality disease prevention and control solutions, and work with everyone to build a healthy and prosperous aquaculture ecological environment.